Revenue: The sum of all revenue fields included for a company's operating activities.
Can-Fite Biopharma Ltd (CANF) had Revenue of $0.67M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$0.67M |
$-7.88M |
|
-- |
|
$0.67M |
|
$8.80M |
|
$-8.13M |
|
$0.25M |
|
$-7.88M |
|
$-7.88M |
|
$-7.88M |
|
$-7.88M |
|
$-7.88M |
|
$-7.88M |
|
$-8.13M |
|
$-8.12M |
|
0.36M |
|
0.36M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$8.98M |
|
$0.03M |
|
$0.14M |
|
$9.12M |
|
$2.05M |
|
-- |
|
$1.63M |
|
$3.68M |
|
$5.44M |
|
$5.44M |
|
$5.44M |
|
0.50M |
|
| Cash Flow Statement Financials | |
$-7.64M |
|
$1.50M |
|
$6.71M |
|
$4.28M |
|
$4.83M |
|
$0.55M |
|
$0.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1206.23% |
|
-1206.23% |
|
-1205.19% |
|
-1169.14% |
|
-1169.14% |
|
$-7.64M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-144.96% |
|
-144.96% |
|
-86.40% |
|
-144.96% |
|
$10.93 |
|
$-21.07 |
|
$-21.06 |
|